188 related articles for article (PubMed ID: 19442040)
1. The effects of cantharidin and cantharidin derivates on tumour cells.
Liu D; Chen Z
Anticancer Agents Med Chem; 2009 May; 9(4):392-6. PubMed ID: 19442040
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
3. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
4. Medical uses of mylabris in ancient China and recent studies.
Wang GS
J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
6. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
7. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of blister beetles: an ethno-medicinal practice in Karbi community and its experimental evaluation against a murine malignant tumor model.
Verma AK; Prasad SB
J Ethnopharmacol; 2013 Jul; 148(3):869-79. PubMed ID: 23707211
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
10. Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma.
Verma AK; Prasad SB
Cell Biol Toxicol; 2012 Jun; 28(3):133-47. PubMed ID: 22402807
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines.
Kok SH; Chui CH; Lam WS; Chen J; Lau FY; Cheng GY; Wong RS; Lai PP; Leung TW; Tang JC; Chan AS
Int J Mol Med; 2006 May; 17(5):945-9. PubMed ID: 16596285
[TBL] [Abstract][Full Text] [Related]
13. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway.
Gu XD; Xu LL; Zhao H; Gu JZ; Xie XH
Braz J Med Biol Res; 2017 Jul; 50(7):e5920. PubMed ID: 28678918
[TBL] [Abstract][Full Text] [Related]
14. Overview of Cantharidin and its Analogues.
Wang G; Dong J; Deng L
Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
17. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
20. The first two cantharidin analogues displaying PP1 selectivity.
McCluskey A; Keane MA; Walkom CC; Bowyer MC; Sim AT; Young DJ; Sakoff JA
Bioorg Med Chem Lett; 2002 Feb; 12(3):391-3. PubMed ID: 11814804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
